menu search

genelux corporation reports inducement grants under nasdaq listing rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — genelux Corporation (NASDAQ: GNLX), a lat...

September 14, 2023, 11:00 am

genelux corporation strengthens senior management and clinical team with promotions and new hires

WESTLAKE VILLAGE, Calif., July 20, 2023 (GLOBE NEWSWIRE) — genelux Corporation (NASDAQ: GNLX), a late...

July 20, 2023, 8:45 pm

genelux: a game changer in platinum-resistant ovarian cancer

genelux, an immuno-oncology frontrunner, has secured over $65 million in financing and is conducting su...

July 11, 2023, 4:12 am

genelux corporation announces $18 million private placement

WESTLAKE VILLAGE, Calif., June 12, 2023 (GLOBE NEWSWIRE) — genelux Corporation (NASDAQ: GNLX), a late...

June 12, 2023, 11:00 am

Why shares of genelux corporation jumped this week

genelux focuses on hard-to-treat cancers. Its lead therapy is Olvi-Vec, which did well in a phase 2 tri...

June 1, 2023, 5:19 pm

genelux: recent ipo with phase 3 stage oncolytic virus cancer therapy

GNLX IPO-ed recently, but the company has been around for two decades. The company develops an oncolytic virus targeting cancer....

March 26, 2023, 10:50 pm

: genelux ipo prices at bottom of range

genelux Corp. priced its initial public offering at $6 a share, the low end of its $6 to $7 a share ran...

January 26, 2023, 11:40 am

genelux ipo prices at bottom of range

genelux Corp. priced its initial public offering at $6 a share, the low end of its $6 to $7 a share ran...

January 26, 2023, 6:40 am


Search within

Pages Search Results: